Abstract: A number of bacterial species, both pathogenic and non-pathogenic, use the human CEACAM family members as receptors for internalization into epithelial cells. The GPI-linked CEA and CEACAM6 might play a role in the innate immune defense, protecting the colon from microbial invasion. Previous studies showed that CEA is released from epithelial cells by an endogenous GPI-PLD enzyme. GPI-PLD activity was reported to be inhibited by several synthetic and natural forms of lipid A. We hypothesized that CEA engagement by Gram-negative bacteria might attenuate CEA release from epithelial cells and that this might facilitate bacterial colonization. We tested the hypothesis by examining the effect of Escherichia coli on CEA release from colorectal cancer cells in a co-culture experiment. A subconfluent monolayer culture of colorectal cancer cells (LS-180, Caco-2 and HT29/219) was incubated with E. coli. While there was a significant reduction in CEA secretion from LS-180 and HT29/219 cells, we found only a small reduction of CEA shedding from Caco-2 cells compared to the level from the untreated control cells. Furthermore, lipid A CELLULAR & MOLECULAR BIOLOGY LETTERS 375 treatment of LS-180 cells inhibited CEA release from the cells in a dosedependent manner. Western blot analysis of total lysates showed that CEA expression levels in cells co-cultured with bacteria did not differ from those in untreated control cells. These results suggest that lipid A of Gram-negative bacteria might play a role in preventing the release of CEA from mucosal surfaces and promote mucosal colonization by bacteria.
INTRODUCTION
A number of Gram-negative bacteria, including pathogenic microorganisms, use the human CEACAM family members as receptors to attach to mucosal epithelial cells [1] . This includes several strains of Escherichia coli, Salmonella and Neisseria species, and Haemophilus influenza. Bacterial binding to different members of this family can result in colonization and uptake of the bacteria [1] [2] [3] [4] . The CEACAM family is a member of the immunoglobulin gene superfamily, which in humans comprises 12 genes and a number of pseudogenes [5, 6] . The physiological functions of CEA family members are not well understood. Very diverse functions for CEA have been suggested in the areas of homotypic and heterotypic cell adhesion [7] , tumor formation, metastasis, signal transduction [8] , apoptosis and host-microbial interaction [1, 5] . CEACAM family members are attached to the cell surface membrane by hydrophobic transmembrane domains (CEACAM1, CEACAM3 and CEACAM4) or by glycosylphosphatidylinositol (GPI) lipid anchors (CEA, CEACAM6, CEACAM7, and CEACAM8). A substantial amount of CEA is produced and released in the normal colon epithelium. Over 50-70 mg of CEA is released per day from the apical surface of mature epithelial cells into the gut lumen in healthy adults [9, 10] . Considering the position of CEA and other CEACAMs in the apical glycocalyx of the human colonic mucosa and their ability to bind microorganisms, it has been suggested that these molecules may play a role in the innate immune defense mechanisms that protect the colonic mucosa from microbial colonization and invasion [11] [12] [13] . The large intestine harbors the vast majority of the bacteria in the gut. It has been hypothesized that GPI-anchored CEA and CEACAM6 bind and trap microorganisms, preventing them from reaching down to the microvilli and invading the epithelial cell [14] . The constant and rapid release of vesicles from CEA-containing microvilli membranes might represent a mechanism for trapping and rapidly eliminating attached bacteria [11] . It was previously demonstrated that CEA protein is released from human colorectal cells by an endogenous GPI-specific phospholipase D (GPI-PLD) enzyme [15, 16] . It was also previously shown that the purified GPI-PLD is inhibited by micromolar concentrations of natural lipid A prepared from several different bacteria [17, 18] . These findings led us to hypothesize that Gramnegative CEA-binding bacteria might modulate detachment from epithelial cells using lipid A to block CEA release from the cell surface. In this study, we tested this hypothesis by examining the ability of E. coli to inhibit CEA release from CE-producing cancer cells in co-culture experiments. We also studied the direct effect of purified lipid A on CEA release from these cells.
MATERIALS AND METHODS

Chemicals
Unless otherwise noted, all chemicals were purchased from Sigma Aldrich and were prepared and stored according to the manufacturers' instructions.
Bacterial strain and growth media E. coli ATCC 25922 was taken from an LB agar plate, suspended in LB broth and allowed to grow overnight in a shaking incubator at 37ºC. To quantify the number of bacteria being added to the human cell cultures, serial dilutions of bacterial cultures were plated and OD 550 readings were used to calculate colonyforming units (CFU) according to a standard curve.
Eukaryotic and bacterial cell co-culture
The human colon carcinoma cell lines LS-180, HT29/219 and Caco-2 were obtained from the National Cell Bank of Iran (NCBI, Pasteur Institute, Tehran). Cells were seeded at a concentration of 2 x 10 5 cells per 2-cm well in 4-well tissue culture plates. The cells were grown as monolayers in 500 μl of DMEM containing 10% FBS in the absence of antibiotics and then incubated at 37ºC in a humidified atmosphere of 5% CO 2 and allowed to obtain 80 to 90% confluence. The culture media were then removed and replaced with 200 μl of fresh medium containing 1 x 10 6 CFU of E. coli bacteria, which were co-cultured with the human cancer cells for 8 h. The medium for the control cells was replaced with medium without bacteria. The cell culture media from a duplicate set of wells was collected after 8 h of incubation. The media were centrifuged at 3000 x g for 5 min to remove any floating cells and then the supernatant was transferred to a new tube and centrifuged for another 5 min at 4ºC and 10,000 x g to remove membrane vesicles and debris. The number of viable cells in each well was determined using the trypan blue assay technique and counted using a hemocytometer. The amount of CEA released into the culture medium was determined via ELISA (CanAg Diagnostics AB) according to the manufacturer's protocol. The concentration was normalized by cell number and expressed as nanograms per 5 x 10 5 living cells.
Effect of lipid A on CEA release from colorectal cancer (CRC) cells
Pure lipid A, diphosphoryl form (Sigma Co.) in an amount of 1 mg/ml was prepared as a sterile stock solution in PBS. After brief sonication, aliquots of this stock solution were stored frozen at -20ºC. Immediately prior to use, aliquots of the desired amounts were dispersed by incubation at 37ºC for 5 min in fresh culture media followed by brief sonication. To investigate the effect of lipid A on CEA release, a duplicate aliquot of LS-180 cells was seeded into four-well plates (200,000 cells/well in 250 μl medium) and allowed to grow to subconfluence. Subconfluent cells were washed twice with PBS and then incubated in fresh DMEM medium with or without FBS containing lipid A (20-100 μM). The cells were incubated at 37ºC for 8 h in a humidified incubator. The medium for the controls was replenished with medium without lipid A. The cell culture medium from a duplicate set of wells was collected after 8 h of incubation. To remove any cell debris, the media were centrifuged as described above. The total number of viable cells in each well was determined using the trypan blue assay. The effect of lipid A on the secretion of CEA in cell culture supernatants was determined by measuring the amount of CEA protein as described above.
Analysis of human CEA expression by immunoblotting
After co-culturing with bacteria, monolayer cultures of human colon carcinoma cells were removed from plastic surfaces by scraping in a lysis buffer containing 50 mM Tris-HCl (pH 7.5), 0.5 M NaCl, and 1% NP-40 supplemented with an anti-protease cocktail (Roche Applied Science). 40 μg of total protein was subjected to electrophoresis on 7.5% SDS-PAGE. After electrophoresis, the gels were transferred onto a polyvinylidene fluoride (PVDF) membrane (Millipore) and analyzed for CEA protein content as described [19] . The membranes were also probed with anti-actin antibody as an internal control for protein loading.
RESULTS
Effect of bacterial cell co-culture on CEA release from epithelial cancer cells CEA is released from the apical surface of intestinal cells into the gut lumen. It is excreted with the feces. To test the hypothesis that interaction with Gramnegative bacteria might attenuate CEA release from mucosal epithelial cells, we examined the ability of E. coli to inhibit CEA release from human colon cancer cells in a co-culture experiment. The assay was conducted on LS-180, HT29/219 and Caco-2 cells because of their high levels of CEA expression and release into the medium. This facilitated monitoring using the non-radioactive method of determination of CEA levels in the medium. Subconfluent monolayer cultures of LS-180, HT29/219 and Caco-2 cells were co-cultured with 1 million CFU of bacteria as described in the Materials and Methods section. After 8 h of incubation with the bacteria, cell culture supernatants were removed and examined for CEA concentration via ELISA. A consistent reduction in CEA secretion was observed in the cell culture of the three cell lines. There was no difference in cell viability between the controls and experiments, as verified using the trypan blue exclusion assay. Although the reduction in CEA release from Caco-2 cells was not statistically significant compared to the release from the controls, there was a significant inhibition of CEA release when LS-180 and HT29/219 cells were incubated with E. coli (Fig. 1) .
Respective reductions of 21% and 18.2% in CEA secretion were observed after 8 h incubation of LS-180 and HT29/219 cells with E. coli (p < 0. 05). The experiment was performed in triplicate and the data produced two times per experimental set up. The average value from all of the experiments is shown in Fig. 1 . 6 CFU of E. coli in complete medium without antibiotics. The amount of CEA released into the supernatant was determined using a commercial CEA ELISA kit. Medium from untreated cells served as a control. The results are expressed as means and standard error of three separate experiments performed in duplicate and normalized to 5 x 10 5 living cells per well. Statistical differences between the groups were calculated using the Mann-Whitney test. *p < 0.05.
To determine whether the presence of E. coli diminishes CEA shedding directly or via the modulation of CEA expression, we compared the amount of CEA protein in CRC cells co-cultured with E. coli and that from the control cells using immunoblotting. Western blot analysis of the total lysates showed that the levels of CEA protein did not differ between CRC cells incubated with E. coli and the control cells (Fig. 2) . Fig. 2 . Western blot analysis of CEA expression in total lysates from CRC cells co-cultured with E. coli. The cells were grown to subconfluence in four-well plates and then incubated for 8 h with 1 x 10 6 CFU of bacteria in a serum-containing medium. Cell lysates from untreated cells served as a control. The blot was probed with anti-beta-actin antibody as an internal control of protein loading.
Effect of GPI-PLD inhibitor on CEA secretion
As mentioned in the Introduction, previous studies have indicated that soluble CEA is probably released from the cell surface through the action of an endogenous GPI-PLD. Lipid A has also been shown to inhibit mammalian GPI-PLD activity in vitro [18, 19] . To investigate if lipid A, the lipid anchoring moiety of Gram-negative bacterial lipopolysaccharides, inhibits CEA release from epithelial cells, we examined the direct effect of purified lipid A on CEA release from CRC cells. Subconfluent LS-180 cultures were exposed to lipid A at concentrations of 20-100 μM for 8 h. Thereafter, the culture media were collected and assayed for CEA levels using ELISA as described above. After 8 h incubation, no significant difference in cell viability was noted between the lipid A-treated and control groups. Lipid A significantly reduced CEA release from LS-180 cells into the culture supernatants (Fig. 3) and the effect was dose-dependent. A 16.8% decrease in CEA secretion was observed after 8 h of continuous exposure of LS-180 cells to 20 μM pure lipid A. An over 29% reduction in CEA secretion was observed after treatment of the cells with 100 μM lipid A. Because of its low solubility, it was relatively difficult to disperse lipid A. This may account for the occasional poor reproducibility of the results, especially at high concentrations. 
DISCUSSION
The colonic mucosa is constantly exposed to a large number of pathogenic and non-pathogenic microorganisms. The binding of bacteria to mucosal cells involves the interaction of specific bacterial adhesive factors and host cell membrane receptors. In polarized colonic epithelial cells, CEACAMs are generally expressed on the apical membrane. Several Gram-negative bacterial species expressing adhesins adhere to epithelial cells by binding to the GPIanchored CEACAM family members, namely CEA and CEACAM6, as cellular receptors [1, [20] [21] [22] [23] [24] . CEACAM family members, including CEA, have been suggested to play a role in the innate immune defense, protecting the colon from microbial attack [14] . During colonization of mucosal surfaces, incoming bacteria must counteract multiple host defenses. The bacteria might employ a variety of strategies to subvert host defense to promote colonization or proliferation in the gut epithelium. In vitro studies have suggested that bacterial engagement of human CEACAMs can block cell detachment and exfoliation [25, 26] . It was previously reported that the GPI-linked CEA is released from the epithelial cell surface through the action of an endogenous GPI-PLD enzyme [15, 16] . Moreover, Low et al. [17, 18] demonstrated that several forms of natural and synthetic lipid A are strong inhibitors of plasma-derived GPI-PLD enzyme in vitro. We hypothesized that the Gram-negative bacteria might use the lipid A moiety of their cell envelope to block CEA release from the epithelial cell surface. To test this hypothesis, we examined the ability of E. coli to inhibit CEA shedding from human CEA-producing cells in a co-culture experiment. We incubated CRC cells (HT29/219, LS-180 and Caco-2) with E. coli for a period of 8 h. We found a significant reduction in CEA release from LS-180 and HT29/219 cells incubated with E. coli in comparison to the controls (Fig. 1) . We also observed a non-significant trend for inhibition of CEA release after incubation of Caco-2 cells with E. coli. HT29/219, LS-180 and Caco-2 cells all express and release CEA into the culture media. Our previous study showed that the level of CEA expression in the LS-180 cell line is 8 times greater than that of Caco-2 cells [19] . Longer times of incubation with bacteria might be required to observe a significant decrease in CEA release from cells producing low levels of CEA. We also evaluated the effect of the known GPI-PLD inhibitor, lipid A, on CEA release from LS-180 cells. We used different concentrations of purified diphosphoryl form of E. coli lipid A in the culture medium. The results indicated that lipid A treatment significantly reduced CEA release from cancer cells in a dose-dependent manner (Fig. 3) . To address whether the observed inhibition of CEA release is due directly to the blocking of CEA shedding by bacteria or indirectly via the blocking of its expression, CEA protein was analyzed in total lysate from LS-180 and Caco-2 cells co-cultured with E. coli. Western blot analysis indicated no significant difference between the experimental and control cells in terms of their respective CEA expression (Fig. 2) . Considering the blocking effect of the GPI-PLD inhibitor lipid A, we are inclined to believe that the reduced CEA release from CRC cells in the co-culture experiment is due to the blocking of CEA shedding from the cell surface by bacteria rather than by suppression of its synthesis.
However, such a mechanism remains speculative. To the best of our knowledge, this is the first study to report the inhibitory effect of lipid A from Gramnegative bacteria on CEA release from human cancer cells. Our study has some limitations. Further experimental evidence is needed to indicate an actual causal relationship between bacterial lipid A and blocking of CEA release from epithelial cells. We used ATCC E. coli strain 25922, which possesses Class II P-fimbriae [27] . Previous studies indicated that various strains of E. coli with type 1 fimbriae interact with CEA and other human CEACAM family members through the Afa/Dr family of adhesins [28] [29] [30] . We have not examined the binding of the E. coli ATCC 25922 strain to CEA. Experiments to show direct interactions of bacteria and CEA are required to demonstrate that suppression of CEA release from epithelial cells by lipid A is dependent on bacterial binding. Quantitative methods such as flow cytometry analysis or realtime RT-PCR should also be used to detect any change in CEA expression in CRC cells co-cultured with E. coli. Experiments using other epithelial cell lines and with Dr-positive bacteria are in progress in our laboratory to investigate whether blocking of CEA release is a general effect of Gram-negative bacteria on human intestinal epithelial cells. We have shown that Gram-negative E. coli blocks CEA release from epithelialderived cancer cells, possibly through its lipid A moiety. This mechanism might allow CEA-binding of Gram-negative bacteria to counteract the innate immune response mediated by CEA release from the surface of epithelial microvilli and promote mucosal colonization. Further investigation is necessary to understand the exact interactions between CEA and CEA-binding bacteria in vivo. 
